Growth Metrics

Astrana Health (ASTH) Return on Sales (2016 - 2025)

Historic Return on Sales for Astrana Health (ASTH) over the last 17 years, with Q3 2025 value amounting to 0.0%.

  • Astrana Health's Return on Sales fell 400.0% to 0.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.02% for FY2024, which is 100.0% down from last year.
  • Latest data reveals that Astrana Health reported Return on Sales of 0.0% as of Q3 2025, which was down 400.0% from 0.02% recorded in Q2 2025.
  • Over the past 5 years, Astrana Health's Return on Sales peaked at 0.32% during Q2 2021, and registered a low of 0.09% during Q4 2021.
  • Its 5-year average for Return on Sales is 0.04%, with a median of 0.04% in 2024.
  • Over the last 5 years, Astrana Health's Return on Sales had its largest YoY gain of 1000bps in 2022, and its largest YoY loss of -2800bps in 2022.
  • Over the past 5 years, Astrana Health's Return on Sales (Quarter) stood at 0.09% in 2021, then surged by 97bps to 0.0% in 2022, then crashed by -1083bps to 0.04% in 2023, then skyrocketed by 49bps to 0.02% in 2024, then surged by 106bps to 0.0% in 2025.
  • Its Return on Sales stands at 0.0% for Q3 2025, versus 0.02% for Q2 2025 and 0.01% for Q1 2025.